申请人:Boehringer Mannheim GmbH
公开号:US04370323A1
公开(公告)日:1983-01-25
A 2-cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methane ##STR1## wherein R is a nitrile or carbamoyl group, and R.sub.1 and R.sub.2 each independently is a hydrogen atom, an aliphatic hydrocarbon radical containing up to 10 carbon atoms optionally substituted by hydroxyl, alkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, cyano, 1, 2 or 3 halogens, cycloalkyl, phenyl or phenoxy; nitrile, carboxyl, alkoxycarbonyl or optionally hydrogenated monocyclic heteroaryl or phenyl optionally substituted by alkyl, alkoxy, hydroxy, alkoxcarbonyl, dialkylamino, alkylthio, trifluoromethyl, nitro, carbamoyl, nitrile, sulphonamido, hydroxyalkyl, methylenedioxy, or halogen; or R.sub.1 and R.sub.2, together with the carbon atom to which they are attached, form a ring containing up to 8 ring members of which at least one may be oxygen, sulphur, SO, SO.sub.2 NH, N-alkyl, N-acyl or N-alkoxycarbonylalkyl, and which can be substituted by alkyl, alkoxy, hydroxyl, alkylenedioxy, alkoxycarbonyl, hydroxyalkyl, alkoxycarbonylalkyl, dialkylamino, oxo or 2-cyanoaziridino groups, or can be fused to 1 or 2 benzene rings or can be bridged by alkylene radicals containing up to 3 carbon atoms. The compounds are characterized by cytostatic and immune response-stimulating activity.
一种2-氰基氮杂环丙烷-(1)-2-取代氮杂环丙烷-(1)-甲烷##STR1##其中R是腈基或氨基甲酰基基团,R.sub.1和R.sub.2各自独立地是氢原子,含有多达10个碳原子的脂肪烃基,可选地被羟基,烷氧基,氨基,烷基氨基,二烷基氨基,烷氧羰基,氰基,1,2或3个卤素,环烷基,苯基或苯氧基取代;腈基,羧基,烷氧羰基或可选地氢化的单环杂芳基或苯基,可选地取代为烷基,烷氧基,羟基,烷氧羰基,二烷基氨基,烷基硫醇,三氟甲基,硝基,氨基甲酰基,腈基,磺酰胺基,羟基烷基,亚甲氧基,或卤素;或R.sub.1和R.sub.2与它们连接的碳原子一起形成一个环,包含多达8个环成员,其中至少一个可以是氧,硫,SO,SO.sub.2 NH,N-烷基,N-酰基或N-烷氧羰基烷基,并且可以由烷基,烷氧基,羟基,亚甲二氧基,烷氧羰基,羟基烷基,烷氧羰基烷基,二烷基氨基,氧代或2-氰基氮杂环丙烷基团取代,或可以与1或2个苯环融合,或可以由含有多达3个碳原子的烷基基团桥接。该化合物具有细胞毒性和免疫应答刺激活性。